Dr. Ala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
751 N Rutledge St
Springfield, IL 62702Phone+1 217-545-8417Fax+1 217-545-1903
Education & Training
- University of MinnesotaResidency, Neurology, 1986 - 1987
- University of MinnesotaResidency, Neurology, 1981 - 1985
- University of Minnesota Medical SchoolClass of 1981
Certifications & Licensure
- IL State Medical License 1999 - 2026
- MN State Medical License 1985 - 2000
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) Start of enrollment: 2013 Mar 01
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 1 citationsCognitive Component Structure of a Neuropsychological Battery Administered to Cognitively-Normal Adults in the SIU Longitudinal Cognitive Aging Study.Madison G Hollinshead, Albert Botchway, Kathleen E Schmidt, Gabriella L Weybright, Ronald F Zec
Gerontology & Geriatric Medicine. 2022-10-17 - When Determining Brain Death in Adults, Time Is of the Essence! The Last Nail in the Coffin of Dual Examination in Brain Death.Gregory Kapinos, Thomas A. Ala
Neurology. 2021-03-09 - Many caregivers of persons with memory loss or Alzheimer's disease are unaware of the abilities of their persons with AD to recall their drugs and medical histories.Thomas A. Ala, GaToya Simpson, Marshall T. Holland, Vajeeha Tabassum, Maithili Deshpande
Dementia. 2020-10-01
Press Mentions
- Safety and Efficacy of Edonerpic Maleate for Patients with Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical TrialJuly 8th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: